A Case of Nivolumab-induced Hypophysitis in a 72-year-old Female with Metastatic Melanoma
DOI:
https://doi.org/10.46570/utjms.vol11-2023-898Keywords:
Hypophysitis, hematology/oncology, melanoma, metastatic cancer, Complications of ImmunotherapyReferences
Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Practice & Research Clinical Endocrinology & Metabolism. 2019;33(6):101371. doi:10.1016/j.beem.2019.101371 https://pubmed.ncbi.nlm.nih.gov/31866206/
Imga NN, Yildirim AE, Baser OO, Berker D. Clinical and hormonal characteristics of patients with different types of hypophysitis: A single-center experience. Archives of Endocrinology and Metabolism. 2019;63(1):47-52. doi:10.20945/2359-3997000000102 https://pubmed.ncbi.nlm.nih.gov/30864631/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Vikhyathi Pallerla, MS, Avish Persaud, MS, Divya Vijendra
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).